Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer
Ahmed Elkamhawy, Qili Lu, Hossam Nada, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6535-6535
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

The extracellular matrix as hallmark of cancer and metastasis: From biomechanics to therapeutic targets
Jelle J. F. Sleeboom, Gilles van Tienderen, Katja Schenke‐Layland, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 728
Closed Access | Times Cited: 82
Recent progress in targeted therapy for non-small cell lung cancer
Yanxia Xiao, Pu Liu, Jie Wei, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 44
Chemotherapy as a regulator of extracellular matrix-cell communication: Implications in therapy resistance
Jordi Gonzalez‐Molina, Lidia Moyano‐Galceran, Andrew Single, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 224-236
Closed Access | Times Cited: 43
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 43
Extracellular Matrix Dynamics as an Emerging yet Understudied Hallmark of Aging and Longevity
Cyril Statzer, Ji Young Cecilia Park, Collin Y. Ewald
Aging and Disease (2023) Vol. 14, Iss. 3, pp. 670-670
Open Access | Times Cited: 40
A highly selective humanized DDR1 mAb reverses immune exclusion by disrupting collagen fiber alignment in breast cancer
Junquan Liu, Huai-Chin Chiang, Wei Xiong, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 6, pp. e006720-e006720
Open Access | Times Cited: 28
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracellular traps formation in hepatocellular carcinoma
Xiaotian Shen, Sun‐Zhe Xie, Xin Zheng, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 9
Progress in the treatment of diabetic cardiomyopathy, a systematic review
Yiyi Shou, X M Li, Quan Fang, et al.
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 2
Open Access | Times Cited: 9
DDR1-targeted therapies: current limitations and future potential
Donglin Wu, Zihui Ding, Tao Lü, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103975-103975
Closed Access | Times Cited: 9
Discoidin domain receptor 1(DDR1) promote intestinal barrier disruption in Ulcerative Colitis through tight junction proteins degradation and epithelium apoptosis
Xiaoli Li, Qianqian Li, Xiong Bin, et al.
Pharmacological Research (2022) Vol. 183, pp. 106368-106368
Closed Access | Times Cited: 35
Collagen-induced DDR1 upregulates CXCL5 to promote neutrophil extracellular traps formation and Treg infiltration in breast cancer
Hong Li, Jiayi Li, Zhengyang Bai, et al.
International Immunopharmacology (2023) Vol. 120, pp. 110235-110235
Closed Access | Times Cited: 20
Targeting collagen homeostasis for the treatment of liver fibrosis: Opportunities and challenges
Theerut Luangmonkong, Warisara Parichatikanond, Peter Olinga
Biochemical Pharmacology (2023) Vol. 215, pp. 115740-115740
Open Access | Times Cited: 19
Biomarker discovery and application—An opportunity to resolve the challenge of liver cancer diagnosis and treatment
Jingtao Chen, Chao Niu, Ning Yang, et al.
Pharmacological Research (2023) Vol. 189, pp. 106674-106674
Open Access | Times Cited: 18
Fibroblasts in liver cancer: functions and therapeutic translation
Silvia Affò, Aveline Filliol, Gregory J. Gores, et al.
˜The œLancet. Gastroenterology & hepatology (2023) Vol. 8, Iss. 8, pp. 748-759
Open Access | Times Cited: 18
Multifaceted collagen-DDR1 signaling in cancer
Hua Su, Michael Karin
Trends in Cell Biology (2023) Vol. 34, Iss. 5, pp. 406-415
Closed Access | Times Cited: 18
Material matters: exploring the interplay between natural biomaterials and host immune system
Alok Shiomurti Tripathi, Magdi E. A. Zaki, Sami A. Al‐Hussain, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
DNA Methylation Profiling Distinguishes Adamantinoma-Like Ewing Sarcoma From Conventional Ewing Sarcoma
Karen J. Fritchie, Baptiste Ameline, Vanghelita Andrei, et al.
Modern Pathology (2023) Vol. 36, Iss. 11, pp. 100301-100301
Closed Access | Times Cited: 15
Proteogenomic analysis of enriched HGSOC tumor epithelium identifies prognostic signatures and therapeutic vulnerabilities
Nicholas W. Bateman, Tamara Abulez, Anthony R. Soltis, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5
DDR2/STAT3 Positive Feedback Loop Mediates the Immunosuppressive Microenvironment by Upregulating PD-L1 and Recruiting MDSCs in Oxaliplatin-Resistant HCC
Wenfeng Liu, Feng Zhang, Bing Quan, et al.
Cellular and Molecular Gastroenterology and Hepatology (2024) Vol. 18, Iss. 4, pp. 101377-101377
Open Access | Times Cited: 5
Role of Collagen Regulators in Cancer Treatment: A Comprehensive Review
Tanuja Angre, Adarsh Kumar, Ankit Kumar Singh, et al.
Anti-Cancer Agents in Medicinal Chemistry (2022) Vol. 22, Iss. 17, pp. 2956-2984
Closed Access | Times Cited: 20
Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment—A Paradigm Shift in Oncology
Azhar Ali
Pharmaceuticals (2024) Vol. 17, Iss. 2, pp. 246-246
Open Access | Times Cited: 4
Research progress of DDR1 inhibitors in the treatment of multiple human diseases
Mengying Liu, Jifa Zhang, Xiaoxue Li, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116291-116291
Closed Access | Times Cited: 4
Discovery of a prominent dual-target DDR1/EGFR inhibitor aimed DDR1/EGFR-positive NSCLC
Xuebao Wang, Ying Lu, Siyu Chen, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107500-107500
Closed Access | Times Cited: 4
Differences between lung adenocarcinoma and lung squamous cell carcinoma: Driver genes, therapeutic targets, and clinical efficacy
Yue Shen, Jie-Qi Chen, Xiangping Li
Genes & Diseases (2024) Vol. 12, Iss. 3, pp. 101374-101374
Open Access | Times Cited: 4
Identification of Common Angiogenesis Marker Genes in Chronic Lung Diseases and Their Relationship with Immune Infiltration Based on Bioinformatics Approaches
Lu Liu, Man Wang, Shihuan Yu
Biomedicines (2025) Vol. 13, Iss. 2, pp. 331-331
Open Access
Page 1 - Next Page

Scroll to top